The Global L-Arabinose market size was worth US$ YY billion in 2019 and further predicted to reach US$ YY billion by 2027, at a CAGR of YY% during the forecast period (2022-2029).
L-Arabinose is an isomer that arises naturally and is an integral part of polysaccharides in plants. Important bacterial numbers consist of an inducible operon of arabinose that codes for a set of transporters and enzymes. This helps L-arabinose to be used in microbial cultures as a sole source of carbon. It is present in nature as a component of biopolymers, such as hemicellulose and pectin. The biomolecular study is ongoing on the L-arabinose operon, also known as the araBAD operon. To recognize, separate, and classify pentose sugar isomerase, L-Arabinose is substantially used as a substrate. In the bio-production of L-ribose, L-Arabinose is also used. L-Arabinose is primarily used in food & beverage and pharmaceutical applications. In-plant cell walls, like corn, wheat, rye, rice, sugar beets, and plant gums, L-Arabinose is a naturally occurring pentose. It is commonly spread as a part of complex nonstarch polysaccharides. In vitro experiments with porcine intestinal mucosa demonstrated an inhibitory effect of L-arabinose on intestinal sucrase activity.
Metrics |
Details |
Market CAGR |
High |
Segments Covered |
By Type, By Application and By Region |
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
Fastest Growing Region |
Asia Pacific |
Largest Market Share |
North America |
To Get a Free Sample Click here
The major factors propelling the L-Arabinose market's growth are the escalated use of L-Arabinose as a substitute for sugar in food and beverages and its added health benefits, making its utilization higher in the pharmaceutical industry. When introduced in the diet, the compound offers benefits such as a reduction in chances of heart disease, prevention of type-2 Diabetes, lowering of blood cholesterol level, and more. Thus, L-arabinose's increasing demand from the Pharmaceutical sector drives the market growth during the forecast period. About 463 million people (aged 20-79 years) lived with Diabetes in 2019, according to the International Diabetes Federation, and the figure is projected to grow to 700 million by 2045. During the forecast era, increasing demand for L-arabinose from the pharmaceutical industry is projected to drive L-arabinose's global market. Moreover, the addition of L-arabinose to a diet is beneficial to prevent obesity. Increasing demand from the food & beverages industry, led by L-arabinose's benefits, is expected to impact the global L-arabinose market shortly positively.
One of the main causes affecting obesity is known to be Sugar. L-arabinose is a natural maize cob sweetener that can be used as a food and beverage sugar substitute. People's eating patterns are unpredictable and unhealthy due to the growing intake of fast food and chemically added additives. This has resulted in increasing obesity cases across the globe. In 2018, 40 million children aged five years or younger worldwide were overweight or obese, according to the World Health Organisation (WHO). To curb sugar intake and tackle obesity, the health-conscious population is shifting towards natural ingredients and substituting Sugar, leading to a boost in market growth.
When used as a part of the diet, L-arabinose offers benefits such as reducing chances of development of heart diseases, lowering the blood cholesterol level, managing body weight and composition and preventing Type 2 diabetes. According to the International Diabetes Federation, approximately 463 million adults (aged 20–79 years) were living with Diabetes in 2019, and the number is expected to rise to 700 million by 2045. Rising demand for L-arabinose from the pharmaceutical sector is expected to drive the global L-arabinose market during the forecast period.
Lack of awareness concerning L-Arabinose's health advantages among individuals is a key factor expected to curtail the growth of the global market over the forecast period. L-Arabinose is a non-caloric sugar that can regulate the metabolism of glucose and lipids and inhibit obesity. The effect of L-arabinose on metabolic syndrome, a combination of medical disorders that raise the risk of Diabetes and cardiovascular disease, has been defined in a few studies.
The outbreak of COVID-19 has negatively impacted the growth of the L-Arabinose market globally. The disruption in the supply chain has majorly impacted the growth of the market amidst the pandemic. Therefore, the COVID-19 pandemic has hampered the market value of the L-Arabinose market in 2020.
Based on the Type, the L-Arabinose market has been classified into Food Grade and Pharma Grade.
Food Grade dominated the global market in 2019, whereas the Pharma Grade is expected to present considerable growth shortly. The increasing use of L-Arabinose as a substitute for Sugar has made it a key ingredient in food and beverage processing. The increasing consumption of food and beverages, swift food, drives the demand for L-Arabinose during the forecast period.
L-Arabinose is segmented based on Application, which includes Food and Beverages, Pharmaceuticals, Others.
Food and Beverages held the dominant position in the global market during the forecast period. The increasing utilization of L-Arabinose in the Food and Beverage Industry as a sugar substitute coupled with the boost in the food and beverage processing sector across the globe supports the segment growth during the forecast period. Moreover, Pharmaceutical is expected to project a considerable CAGR during the forecast period. L-Arabinose's added benefits, such as management of Cholesterol levels, prevention of diabetes and heart diseases, propels lucrative market growth opportunities during the forecast period. In metabolic diseases such as Diabetes and reduced tolerance to glucose, glycaemic regulation is important. L-arabinose blocks the hydrolysis of sucrose into glucose and fructose. When L-arabinose replaced sucrose in beverages, Sucrose substitution in cereal foods did not affect glucose responses, although, In a cocktail, L-arabinose without sucrose did not impact glucose responses. Therefore, it is possibly a successful idea to substitute sucrose with L-arabinose to lower glycaemic and insulin responses.
Based on geography, the study analyzes the L-Arabinose market globally, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.
Asia-Pacific held a dominant position in the global L-Arabinose market in 2019. In Asia-pacific, the boost in the Food and beverage sector has stirred the demand for L-Arabinose and the changing lifestyles and shift towards fast food culture. Moreover, North America is expected to represent significant growth in terms of value during the forecast period. The increasing use in the pharmaceutical sector is expected to propel market growth across the region. The L-Arabinose market for the Asia Pacific is expected to observe rapid growth over the forecast period, backed by the increasing prevalence of major conditions such as heart diseases, obesity, Diabetes and more.
The L-Arabinose market is highly competitive, owing to the presence of big food brands. The key L-Arabinose players contributing to the growth of the global market include Danisco, Healtang, Nuara Biotech, Thomson Biotech, Xieli Biotechnology, MAK Wood, Futaste, Huakang Pharmaceutical, Lujian Biological, Longlive Biotechnology, among others. The major players are adopting new Type launch and expansion strategies for global growth in the L-Arabinose market.
Natural origin Rare Sugar Syrups are manufactured from sustainable wood-based or other biomass hydrolysates by aqueous chromatographic solvent-free separation. The L – Arabinose Syrup offered is natural and non-GMO with applications as flavor and food ingredient. A considerable number of the employees are engaged in developing new products for the international food industry. Today, the Group holds more than 9,300 active patents and patent applications. Their work led to the understanding of the mechanism of CRISPR, the bacterial antiviral defense. CRISPR is a prokaryotic immune system that is both adaptive and inheritable.
Type Portfolio: The Company’s portfolio comprises D-manose, D-Xylose Syrup LR, and among others
The global L-Arabinose market report would provide access to an approx.. 51 market data table, 45 figures and 180 pages.
What is the L-Arabinose market growth?
The market is growing at a High CAGR.
What is L-Arabinose market size in 2021
The L-Arabinose market size was valued at USD YY million in 2021.
Who are the key players in L-Arabinose market?
Thomson Biotech, Xieli Biotechnology, MAK Wood, Futaste, Huakang Pharmaceutical, Lujian Biological.
20% Discount Applied*
Get your free sample proposal with a single click!